This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Wang LX, et al. Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitors. Cancer 126: 322-328, No. 2, 15 Jan 2020. Available from: URL: http://doi.org/10.1002/cncr.32542
About this article
Cite this article
Ipilimumab/nivolumab/pembrolizumab. Reactions Weekly 1791, 151 (2020). https://doi.org/10.1007/s40278-020-74996-z